1.
Combined Immunodeficiency Due to MALT1 Mutations, Treated by Hematopoietic Cell Transplantation
by Punwani, Divya
Journal of clinical immunology, 2015-01-28, Vol.35 (2), p.135-146
2.
HLA dosage effect in narcolepsy with cataplexy
by van der Heide, Astrid
Immunogenetics (New York), 2014-10-03, Vol.67 (1), p.1-6
3.
Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity
by Meysman, Pieter
Immunogenetics (New York), 2017-12-01, Vol.70 (6), p.363-372
4.
Age-dependent HLA profiles of the Israeli population: impact on hematopoietic cell donor recruitment and availability
by Israeli, Moshe
Immunogenetics (New York), 2014-07-13, Vol.66 (9-10), p.525-533
5.
Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms
by D’Orsogna, Lloyd
Immunogenetics (New York), 2017-07-17, Vol.69 (8-9), p.631-641
6.
Towards clinical transplantation tolerance
by Claas, Frans HJ
The Lancet (British edition), 2003, Vol.361 (9368), p.1489-1490
7.
Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survival
by Guberina, Hana
Immunobiology (1979), 2016, Vol.222 (3), p.536-543
8.
Incidence of cancer in kidney-transplant recipients: A long-term cohort study in a single center
by Wisgerhof, Hermina C
Cancer epidemiology, 2010, Vol.35 (2), p.105-111
9.
Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism
by van de Mast, Bj
The Lancet (British edition), 1994-03-26, Vol.343 (8900), p.753-757
10.
Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept
by Doxiadis, Ilias IN
The Lancet (British edition), 1996, Vol.348 (9031), p.850-853
11.
Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies
by CLAAS, F. H. J
Psychopharmacologia, 1989, Vol.99 Suppl (S1), p.S113-S117
12.
Tolerogenic immunosuppression for organ transplantation. Commentary
by CLAAS, Frans H. J
The Lancet (British edition), 2003, Vol.361 (9368), p.1502-1510
13.
Lack of effect of different cytokines on expression of membrane-bound regulators of complement activity on human uveal melanoma cells
by Blom, D J
Journal of interferon & cytokine research, 1997-11, Vol.17 (11), p.695-700
14.
Immunological effect of co-trimoxazole on platelets
by Claas, F H
British Medical Journal, 1979-10, Vol.2 (6195), p.898-899
15.
Correspondence of the monocyte antigen HMA-1 to the non-HLA antigen 9a
by JAGER, M. J
Immunogenetics (New York), 1986, Vol.23 (2), p.71-77
16.
Interaction between des-Tyr1-γ-endorphin and HLA class I molecules: serological detection of an HLA-A2 subtype
by CLAAS, F. H. J
Immunogenetics (New York), 1985, Vol.22 (4), p.309-314
17.
Supplement II: Abstracts of the international symposium on Skin Carcinogenesis in man and in experimental models. Heidelberg, 29–31 October 1991 (pp S61–S88)
by Burkhart, B. A.
Journal of cancer research and clinical oncology, 1991-11, Vol.117 (6), p.S61-S83
18.
Preeclampsia Is Characterized by Placental Complement Dysregulation
by Buurma, Aletta
Hypertension (Dallas, Tex. 1979), 2012-11, Vol.60 (5), p.1332-1337
19.
Antimyeloperoxidase antibodies and adverse reactions to clozapine
by Jaunkalns, Robert
The Lancet (British edition), 1992, Vol.339 (8809), p.1611-1612
